YU71603A - Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenja - Google Patents
Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenjaInfo
- Publication number
- YU71603A YU71603A YU71603A YUP71603A YU71603A YU 71603 A YU71603 A YU 71603A YU 71603 A YU71603 A YU 71603A YU P71603 A YUP71603 A YU P71603A YU 71603 A YU71603 A YU 71603A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- treatment
- combination
- chemotherapeutic agents
- proliferative diseases
- epothilone analogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Prikazani su preparati i postupci korisni u lečenju i prevenciji proliferativnih bolesti.[The present invention provides use of a compound in the manufacture of a medicament to inhibit 11ГЎ-HSD activity, wherein the compound is selected from glycyrrhetinic acid derivatives, progesterone and progesterone derivatives.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60275801A | 2001-03-14 | 2001-03-14 | |
US31639501P | 2001-08-31 | 2001-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU71603A true YU71603A (sh) | 2006-05-25 |
Family
ID=47748799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU71603A YU71603A (sh) | 2001-03-14 | 2002-03-05 | Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenja |
Country Status (1)
Country | Link |
---|---|
YU (1) | YU71603A (sh) |
-
2002
- 2002-03-05 YU YU71603A patent/YU71603A/sh unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0105772D0 (en) | Use | |
PL365285A1 (en) | Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs | |
DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
ZA200501098B (en) | Novel use of benzothiazole derivatives | |
AU5584901A (en) | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease | |
MXPA05001581A (es) | Algunas imidazopiridinas novedosas y su uso. | |
NZ514234A (en) | N-cyanomethylamides as protease inhibitors | |
MXPA04009163A (es) | Nuevos compuestos. | |
MXPA04006553A (es) | Compuesto de 4-oxoquinolina y uso del mismo como inhibidor de integrasa de vih. | |
HUP0400203A3 (en) | Use of combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases, for preparation of pharmaceutical compositions | |
WO2001039762A3 (en) | Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system | |
MXPA04012965A (es) | Inhibidores virales. | |
SG148177A1 (en) | Novel cis-imidazolines | |
WO2002096363A3 (en) | Method for treating fibrotic diseases or other indications | |
EP0249735A3 (en) | Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress | |
TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
MY128014A (en) | Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors | |
GB0130677D0 (en) | Medicaments and novel compounds | |
MY133527A (en) | Isoquinoline derivatives | |
AU2001249684A1 (en) | Nasal administration of agents for the treatment of gastroparesis | |
NZ511559A (en) | Use of staurosporine derivatives for treating ocular neovascular diseases | |
YU71603A (sh) | Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenja | |
AU6826700A (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
EA200601514A1 (ru) | Производные пиперазинмочевины для лечения эндометриоза | |
AU4258601A (en) | Divided dose therapies with vascular damaging activity |